Chrysin targets myeloid‐derived suppressor cells and enhances tumour response to anti‐PD‐1 immunotherapy
- DOI
- 10.1002/ctm2.1019
- Published
- 2022-09
- Container
- Clinical and Translational Medicine
- Publisher
- Wiley
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1002/ctm2.1019,
title = {Chrysin targets myeloid‐derived suppressor cells and enhances tumour response to anti‐PD‐1 immunotherapy},
author = {Yinan Li and Ru Yang and Xiu Huang and Caihong Chen and Daolei Dou and Qianqian Wang and Xinying Wu and Huijuan Liu and Tao Sun},
year = {2022},
journal = {Clinical and Translational Medicine},
doi = {10.1002/ctm2.1019},
url = {https://doi.org/10.1002/ctm2.1019}
}RIS
TY - JOUR TI - Chrysin targets myeloid‐derived suppressor cells and enhances tumour response to anti‐PD‐1 immunotherapy AU - Yinan Li AU - Ru Yang AU - Xiu Huang AU - Caihong Chen AU - Daolei Dou AU - Qianqian Wang AU - Xinying Wu AU - Huijuan Liu AU - Tao Sun PY - 2022 JO - Clinical and Translational Medicine DO - 10.1002/ctm2.1019 UR - https://doi.org/10.1002/ctm2.1019 ER -
APA
Li, Y., Yang, R., Huang, X., Chen, C., Dou, D., Wang, Q., Wu, X., Liu, H., & Sun, T. (2022). Chrysin targets myeloid‐derived suppressor cells and enhances tumour response to anti‐PD‐1 immunotherapy. Clinical and Translational Medicine. https://doi.org/10.1002/ctm2.1019
Source records
- crossref · retrieved 2026-09-26T03:13:34.080Z